GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Catalent Inc.
Catalent is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. Its share price depends on the overall health of the biotech sector and the volume of outsourced drug, vaccine, and gene therapy production.
Share prices of companies in the market segment - Pharma tests
Catalent is one of the world's largest contract manufacturing organizations (CDMOs), providing drug development, manufacturing, and packaging services to the pharmaceutical industry. We've classified it as a "Pharma Tester." The chart below shows how the pharmaceutical outsourcing sector is faring.
Broad Market Index - GURU.Markets
Catalent is one of the world's largest contract manufacturing organizations (CDMOs), helping pharmaceutical companies develop and manufacture drugs. Its key role in the pharmaceutical industry makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Catalent compares to it.
Change in the price of a company, segment, and market as a whole per day
CTLT - Daily change in the company's share price Catalent Inc.
The daily fluctuations of Catalent, Inc., a major contract manufacturer for the pharmaceutical industry, reflect the volatility of the healthcare sector. This metric is a measure of the sensitivity of pharmaceutical companies to R&D budgets and production plans.
Daily change in the price of a set of shares in a market segment - Pharma tests
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to the pharmaceutical industry. Its business serves as a barometer for the health of the entire sector. The chart below illustrates the volatility of this industry, helping to assess the dynamics of the CTLT.
Daily change in the price of a broad market stock, index - GURU.Markets
Catalent is one of the world's largest contract manufacturers, helping pharmaceutical companies produce and package their drugs. Its business is a barometer of the health of the entire pharmaceutical industry. Its stock price reflects investment in the sector and influences the market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Catalent Inc.
Catalent, Inc.'s year-over-year performance tells the story of its role as a contract manufacturing organization (CDMO) giant. Its 12-month market cap reflects its manufacturing challenges, but also the huge demand for its drug manufacturing services, including gene therapy and weight loss drugs, making it a key player in the pharmaceutical industry.
Annual dynamics of market capitalization of the market segment - Pharma tests
Catalent, Inc. is one of the world's largest contract drug manufacturers. Its business benefits from the growing number of biotech companies seeking outsourced manufacturing. This chart shows how its key role in this ecosystem and operational challenges impact its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Catalent, a leader in contract drug manufacturing, is an "infrastructure" bet for the entire pharmaceutical industry. Its performance relative to the market is a barometer of the sector's health. The growth of biotech is driving increased orders and allowing it to outpace the market without accepting the risk of clinical failure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Catalent Inc.
Catalent is a giant contract manufacturer for the pharmaceutical industry. Its business depends on pharmaceutical companies' outsourcing budgets. Its monthly price fluctuations reflect news of major manufacturing contracts and its operational efficiency.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Catalent, Inc. is a key partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services. Its business serves as a barometer of R&D activity across the industry. The pharmaceutical sector dynamics chart reflects the pace of new drug introductions, and the more new drugs are introduced, the greater the demand for Catalent's production facilities and technologies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Catalent, Inc. is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry, helping develop and manufacture drugs. Its business serves as a barometer for the entire industry. A broad market graph allows us to assess how its performance, which depends on R&D and drug production volumes, correlates with overall economic trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Catalent Inc.
Catalent, Inc. is one of the world's largest contract development and manufacturing organizations (CDMOs), helping pharmaceutical companies produce drugs. Its weekly stock price is driven by demand for outsourcing and its ability to address manufacturing challenges.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Catalent is one of the largest contract manufacturers of drugs and vaccines for the global pharmaceutical industry. Its business is a barometer of activity in the sector. The chart below will help you understand whether Catalent's performance reflects general trends in the pharmaceutical industry or whether its order book and operational efficiency create their own investment profile.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry. Its business is stable, but the company has faced operational challenges. The chart shows how these internal factors influence its volatility compared to the market.
Market capitalization of the company, segment and market as a whole
CTLT - Market capitalization of the company Catalent Inc.
The market capitalization of Catalent, one of the world's largest contract drug manufacturers (CDMOs), reflects both the overall growth of the pharmaceutical industry and its own operational challenges. Its chart shows how investors weigh its critical role in producing thousands of drugs against challenges related to quality and efficacy.
CTLT - Share of the company's market capitalization Catalent Inc. within the market segment - Pharma tests
Catalent is a global leader in contract drug manufacturing. The company's significant presence in the pharmaceutical sector underscores its key role in the global supply chain. This reflects its manufacturing capacity and its status as an indispensable partner for hundreds of biotech and pharmaceutical companies.
Market capitalization of the market segment - Pharma tests
Below is a chart of the total market capitalization of the contract drug manufacturing (CDMO) sector. Catalent is the absolute global leader. The growth of this market you see reflects the fact that almost the entire pharmaceutical industry, from giants to startups, relies on Catalent's expertise and capacity to manufacture their drugs. It is the "factory" for the entire industry.
Market capitalization of all companies included in a broad market index - GURU.Markets
Catalent is one of the world's largest contract manufacturing organizations (CDMOs), helping pharmaceutical companies develop, manufacture, and package drugs. Its market capitalization reflects its key role in the industry. The chart below shows the importance of outsourcing in the pharmaceutical industry.
Book value capitalization of the company, segment and market as a whole
CTLT - Book value capitalization of the company Catalent Inc.
Catalent's book value is its global network of factories and laboratories, one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. The chart tells the story of a giant whose material base expanded through massive investments during the pandemic and is now undergoing a difficult period of optimization.
CTLT - Share of the company's book capitalization Catalent Inc. within the market segment - Pharma tests
Catalent is one of the world's largest contract drug manufacturers (CDMOs). The chart shows its enormous share of physical assets. Its business is a global network of dozens of factories that provide the material basis for the production of thousands of drugs for the entire pharmaceutical industry.
Market segment balance sheet capitalization - Pharma tests
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry. Their business is extremely capital-intensive, requiring ownership of a global network of manufacturing plants for various forms of drugs, as demonstrated by the book value chart.
Book value of all companies included in the broad market index - GURU.Markets
Catalent's assets comprise a global network of dozens of manufacturing plants, serving as the "factory" for the entire pharmaceutical industry. They manufacture drugs under contract. The chart below visualizes the changing physical scale of this pharmaceutical manufacturing giant.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Catalent Inc.
Catalent is a giant in the contract drug manufacturing industry. Its balance sheet is comprised of a vast network of factories and laboratories around the world. The chart below shows how the market values this capacity. The excess of its market capitalization over its book value reflects the premium it receives for its experience, reputation, and long-term contracts with leading pharmaceutical companies.
Market to book capitalization ratio in a market segment - Pharma tests
Catalent is a global leader in providing services to the pharmaceutical industry, including drug development and manufacturing. Its assets include modern manufacturing facilities around the world. The chart shows how the market values these critical tangible assets and the company's role as an indispensable partner for hundreds of pharmaceutical companies.
Market to book capitalization ratio for the market as a whole
Catalent is a key partner for pharmaceutical companies, providing drug development and manufacturing services. This requires significant investment in plants and equipment. This chart demonstrates how much the market values its technological expertise, long-term contracts, and reputation over and above the cost of these physical assets.
Debts of the company, segment and market as a whole
CTLT - Company debts Catalent Inc.
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry. This chart shows its high debt burden, accumulated through numerous acquisitions. The company's current financial strategy is focused on integrating these assets, improving operational efficiency, and reducing debt.
Market segment debts - Pharma tests
Catalent is a leading global partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services. To serve thousands of customers, the company must continually invest in its facilities and technology. This chart shows how the company's debt load compares to its role as a backbone of the pharmaceutical industry.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Catalent Inc.
Catalent is a large contract manufacturing organization (CDMO) providing drug development and manufacturing services. This chart shows its significant debt load, often associated with acquisitions. Investors should evaluate whether the company can effectively manage its global network and generate cash flow to service its debt.
Market segment debt to market segment book capitalization - Pharma tests
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry. This chart shows the debt burden in the pharmaceutical services sector. It helps understand how the company finances its global manufacturing capacity and acquisitions to serve thousands of clients, from biotech startups to giants.
Debt to book value of all companies in the market
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry. Its business requires constant investment in production lines and technology. This chart of total market debt allows you to assess how the company's debt load compares to its status as an industry leader and overall industry trends.
P/E of the company, segment and market as a whole
P/E - Catalent Inc.
Catalent is one of the world's largest contract development and manufacturing organizations (CDMOs), providing services to the pharmaceutical and biotech industries. This chart shows how investors value this key pharmaceutical outsourcer. The performance depends on the overall health of the sector and the company's ability to effectively manage its numerous manufacturing facilities.
P/E of the market segment - Pharma tests
Catalent is one of the world's largest contract partners for the pharmaceutical industry. The company provides drug development, manufacturing, and packaging services to thousands of clients, from biotech startups to giants. This chart shows the average valuation for the pharmaceutical testing sector, reflecting how investors value outsourcing in the vital drug development chain.
P/E of the market as a whole
Catalent is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. It helps produce drugs ranging from pills to gene therapies. Its business depends on the volume of R&D in the pharmaceutical industry. This general sentiment graph influences biotech funding, but for Catalent, the long-term trend toward manufacturing outsourcing is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Catalent Inc.
Catalent is one of the largest contract manufacturing companies (CDMOs), providing drug development, manufacturing, and packaging services to the pharmaceutical industry. This chart illustrates future revenue expectations, which depend on outsourcing trends in the pharmaceutical industry and the utilization of its global network of manufacturing sites.
%20P%2FE%20Catalent%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Catalent-Inc.&v=1772624833062 "Chart of the company's future (projected) P/E Catalent Inc.")
Future (projected) P/E of the market segment - Pharma tests
Catalent is a leading global partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services. This chart shows overall expectations for the healthcare sector. The position of CTLTs relative to the average reflects market perceptions of their critical role in the drug supply chain, including vaccines and gene therapies.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772624833065 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Catalent, Inc. is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. The company helps develop, manufacture, and package drugs, vaccines, and gene therapies for thousands of clients. This chart of overall market expectations provides a backdrop for assessing the entire biotech sector, whose growth directly supports orders from a giant like Catalent.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772624833079 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Catalent Inc.
Catalent, Inc. is a global leader in contract development and manufacturing organizations (CDMOs). It assists pharmaceutical companies at every stage, from drug development to commercial manufacturing and packaging. Its revenue profile reflects the rapid growth of the biopharmaceutical industry and the demand for its services.
Profit of companies in the market segment - Pharma tests
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to the pharmaceutical industry. The company's business benefits from outsourcing in the pharmaceutical industry. This chart shows the overall profitability of the pharmaceutical testing sector. It reflects the volume of R&D investments by pharmaceutical companies, which directly drives business for all contract manufacturers.
Overall market profit
Catalent is a leading global partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services. Demand for its services is stable and growing in line with the overall drug market. The overall revenue trend in this chart has little bearing on its business, which relies on long-term contracts and pharmaceutical innovation.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Catalent Inc.
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to the pharmaceutical industry. This chart shows analysts' future profit expectations, which are closely linked to their outsourcing forecasts for R&D and manufacturing in the global pharmaceutical industry.
%20profit%20of%20the%20company%20Catalent%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Catalent-Inc.&v=1772624833118 "Graph of future (projected) profit of the company Catalent Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to pharmaceutical companies. Its business thrives on outsourcing within the pharmaceutical industry. This chart shows profitability projections for the entire sector, allowing one to assess how Catalent benefits from biotech companies' focus on accelerating product time to market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772624833123 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Catalent is a leading global partner for the pharmaceutical industry, providing drug development and manufacturing services. Demand for its services depends on industry R&D activity. This schedule can be indirectly affected, as the overall economic situation impacts biotech companies' ability to raise funding.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772624833125 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Catalent Inc.
Catalent is a global leader in contract manufacturing and drug development. This chart demonstrates the high value the market places on its indispensable role in the pharmaceutical ecosystem. Its consistently high multiple reflects long-term partnerships with pharma giants and the critical importance of its services for the development of new drugs.
P/S market segment - Pharma tests
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to the pharmaceutical industry. Revenue is the payment for these comprehensive services. This chart for the pharmaceutical services sector helps assess the premium the market is willing to pay for Catalent's scale and technological capabilities as a key partner to pharmaceutical companies.
P/S of the market as a whole
Catalent is a global leader in contract manufacturing and drug development (CDMO). The company provides services to the pharmaceutical industry across all stages of the product lifecycle. This total market revenue valuation chart helps understand how investors value this giant, whose services are critical to the entire healthcare system.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Catalent Inc.
Catalent is a leading global partner for the pharmaceutical and biotechnology industries, providing drug development, manufacturing, and packaging services. This chart shows how investors estimate future revenue from its contracts. It reflects their expectations for the growth of pharmaceutical outsourcing and Catalent's ability to serve its many clients.
%20P%2FS%20Catalent%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Catalent-Inc.&v=1772624833221 "The graph of the company's future (projected) P/S Catalent Inc.")
Future (projected) P/S of the market segment - Pharma tests
Catalent is one of the world's largest contract manufacturing organizations (CDMOs), providing drug development, manufacturing, and packaging services to the entire pharmaceutical industry. The company's valuation reflects its critical role in the drug supply chain, particularly for complex biologics and gene therapies, enabling its stable growth.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772624833227 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Catalent, Inc. is one of the world's largest contract drug manufacturers (CDMOs). Its business serves as a barometer of activity in the pharmaceutical and biotech industries. Expected revenue growth, as reflected here, depends on the drugs Catalent currently produces.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772624833248 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Catalent Inc.
Catalent is a leading contract development and manufacturing organization (CDMO) for the pharmaceutical industry. This chart shows revenue from providing a wide range of services, including drug development, manufacturing, and clinical supply to thousands of clients worldwide.
Sales of companies in the market segment - Pharma tests
Catalent (CTLT) is a leading global partner for the pharmaceutical industry. The company provides technologies and services for drug development, manufacturing, and packaging. This metric reflects revenue in the pharmaceutical testing and manufacturing sector. Catalent plays a critical role in helping thousands of companies, from giants to startups, bring their products to market.
Overall market sales
Catalent is a leading contract manufacturing organization (CDMO) providing drug development, manufacturing, and packaging services to the pharmaceutical industry. Its business is a barometer of activity in the pharmaceutical industry. This graph of overall economic activity influences R&D investments. Growing markets allow pharmaceutical companies to raise funds and outsource more projects to Catalent.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Catalent Inc.
Catalent is a leading global partner for the pharmaceutical and biotech industries, providing drug development, manufacturing, and packaging services. Its revenue is driven by the volume of pharmaceutical outsourcing. This chart shows analyst revenue expectations, a reliable barometer of the health and innovation of the entire industry.
%20sales%20of%20the%20company%20Catalent%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Catalent-Inc.&v=1772624833321 "Schedule of future (projected) sales of the company Catalent Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Catalent is a leading contract development and manufacturing organization (CDMO) providing services to the pharmaceutical and biotech industries. This chart segments projected revenue by various segments, such as biologics, softgels, and gene therapy. It shows which segment analysts believe is growing the fastest.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772624833354 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Catalent is a global leader in drug development and manufacturing services for the pharmaceutical industry. Its workload is a barometer of the health of the entire industry. This chart shows overall economic sentiment, while Catalent's order book reflects the actual volume of new drug development and production worldwide.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772624833385 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Catalent Inc.
Catalent is a global leader in contract manufacturing and drug development for the pharmaceutical industry. The company's profitability depends on the utilization of its numerous plants and the demand for outsourcing from pharmaceutical giants. The chart shows how this critical partner in the biopharmaceutical industry converts its services into profit.
Market segment marginality - Pharma tests
Catalent is one of the world's leading contract development and manufacturing organizations (CDMOs), providing drug, gene therapy, and vaccine manufacturing services to the pharmaceutical industry. This chart shows the profitability of its manufacturing business. Success depends on the utilization of its numerous plants and long-term contracts with pharmaceutical giants.
Market marginality as a whole
Catalent, Inc. is a leading global partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services. Its business is a barometer of the health of the entire industry. This overall profitability chart reflects the financial health of its clients. Growing margins in the pharmaceutical industry are driving increased outsourcing and growing orders for Catalent.
Employees in the company, segment and market as a whole
Number of employees in the company Catalent Inc.
Catalent is one of the global giants in contract manufacturing for the pharmaceutical industry. The company helps produce thousands of drugs, from pills to gene therapies. This chart illustrates the vast global army of scientists, engineers, and technicians who form the manufacturing backbone of many pharmaceutical companies.
Share of the company's employees Catalent Inc. within the market segment - Pharma tests
Catalent is a global giant in contract manufacturing for the pharmaceutical industry. Its business is to provide its factories and scientists for the production of other companies' drugs. Its vast workforce is a direct indicator of its manufacturing prowess. This chart illustrates its role as one of the largest employers and a pillar of the global pharmaceutical industry.
Number of employees in the market segment - Pharma tests
Catalent, Inc. is a leading global partner for the pharmaceutical industry, providing drug development and manufacturing services. Employment dynamics in the pharmaceutical research sector, as reflected here, directly drive Catalent's business. The more drugs their clients have in development, the greater the demand for their manufacturing capacity and technologies.
Number of employees in the market as a whole
Catalent is a leading global partner for the pharmaceutical industry, providing technologies and services for drug development and manufacturing. The company's business thrives when pharmaceutical and biotech companies are actively pursuing R&D. The growth in overall employment, reflected in this chart, indicates a healthy economy that encourages investment in R&D, which directly utilizes Catalent's production capacity.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Catalent Inc. (CTLT)
Catalent (CTLT) is a global leader in contract manufacturing (CDMO). They produce and package drugs for thousands of pharmaceutical companies. This business requires both high technology (R&D, complex production lines) and a large staff. This metric reflects how much the market values their production capacity, expertise, and contracts per employee.
%20of%20the%20company%20Catalent%20Inc.%20(CTLT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Catalent-Inc.-CTLT&v=1772624833493 "Chart of market capitalization per employee (in thousands of dollars) of the company Catalent Inc. (CTLT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Catalent is a global leader in contract drug manufacturing (CDMO). Scale and technological capabilities are key. This reflects the enormous value of its global network of factories and advanced technologies, which enable it to serve hundreds of pharmaceutical companies worldwide.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772624833496 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Catalent is a leading global partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services (CDMO). It's a large, technology-driven business. This chart demonstrates how Catalent's cost per employee can be high in the biotech services sector, reflecting the company's critical role in the global healthcare value chain.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772624833504 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Catalent Inc. (CTLT)
Catalent is a global CDMO (contract manufacturing) giant. They produce thousands of different drugs, vaccines, and gene therapies for the entire pharmaceutical industry. This chart shows how efficiently the company manages its massive and extremely expensive network of factories, maintaining high utilization and profitability.
%20Chart%20Catalent%20Inc.%20(CTLT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Catalent-Inc.-CTLT&v=1772624833520 "Company Profit Per Employee (in thousands of dollars) Chart Catalent Inc. (CTLT)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Catalent is a global leader in pharmaceutical services, from drug development to manufacturing and packaging. The company's effectiveness depends on the coordinated work of thousands of specialists globally. This chart shows the revenue generated by each employee, reflecting the company's scale and operational strength.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772624833539 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Catalent is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. They help develop, test, and manufacture virtually any form of drug. This chart measures the average profit per employee across the economy. It provides investors with context: how efficient the biotech manufacturing sector, which requires sophisticated equipment and thousands of scientists, is in terms of employee productivity.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772624833546 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Catalent Inc. (CTLT)
Catalent is one of the world's largest CDMOs (distributed drug discovery, manufacturing, and supply chain managers) for the pharmaceutical industry. Its revenue per employee reflects the scale and complexity of its operations. The chart shows how the company helps thousands of clients, from biotech startups to giants, produce life-saving treatments, including vaccines and gene therapies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Catalent-Inc.-CTLT&v=1772624833568 "Sales chart per company employee Catalent Inc. (CTLT)")
Sales per employee in the market segment - Pharma tests
Catalent (CTLT) is a global leader in contract manufacturing (CDMO) and pharmaceutical dosage development. This chart shows the average revenue per employee in the segment. It allows you to assess how effectively Catalent utilizes its vast workforce of scientists and technicians to fulfill contracts compared to its competitors.
Sales per employee for the market as a whole
Catalent (CTLT) is one of the world's largest CDMOs (contract development and manufacturing organizations). They help thousands of pharmaceutical companies produce drugs, from pills to complex gene therapies. They have a massive manufacturing and R&D operation. This metric reflects the revenue generated by their numerous factories and laboratories, based on their tens of thousands of employees.
Short shares by company, segment and market as a whole
Shares shorted by company Catalent Inc. (CTLT)
Catalent (CTLT) is one of the largest contract manufacturers (CDMOs) in the pharmaceutical industry. The company recently faced serious quality issues at its plants (FDA warnings). This chart shows short interest. High values reflect investor concerns about operational failures, high debt loads, and loss of customer confidence. (343)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Catalent-Inc.-CTLT&v=1772624833658 "Short Shares Chart for the Company Catalent Inc. (CTLT)")
Shares shorted by market segment - Pharma tests
Catalent (CTLT) is a key partner for the pharmaceutical industry, providing drug development, manufacturing, and packaging services (CDMO). Their business reflects the health of the entire sector. The chart below shows the overall short position in this sector. It demonstrates how many investors anticipate a decline in biotech R&D budgets or supply chain problems.
Shares shorted by the overall market
Catalent is a giant contract manufacturing organization (CDMO) for Big Pharma and biotech. This chart reflects the overall market pessimism. When investors are fearful, they see smaller biotechs (CTLT clients) losing funding. This means cuts to R&D programs and a drop in orders for Catalent.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Catalent Inc. (CTLT)
Catalent (CTLT) is one of the world's largest contract manufacturing companies (CDMOs) for the pharmaceutical industry, producing a wide range of drugs. The business relies on outsourcing in the pharmaceutical industry. This indicator measures the strength of a trend. It shows when the stock is "overheated" (above 70) due to strong demand or "oversold" (below 30) due to production issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Catalent-Inc.-CTLT&v=1772624833704 "RSI 14 indicator chart for the company's stock Catalent Inc. (CTLT)")
RSI 14 Market Segment - Pharma tests
Catalent is one of the world's largest contract manufacturing organizations (CDMOs) for the pharmaceutical industry. They assist in the development, production, and packaging of drugs (including gene therapies). This chart reflects the overall state of the CDMO sector. It helps understand whether the entire segment is oversold following the pandemic or due to quality issues.
RSI 14 for the overall market
Catalent (CTLT) is a "service" (CDMO) for biotechs, producing drugs for them. This chart is an indicator of R&D budgets. In the euphoria, biotechs are generously funded by investors and immediately hire Catalent. In a panic, the money supply for biotechs is turned off, and contracts for "auxiliary" manufacturing are cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CTLT (Catalent Inc.)
Catalent (CTLT) is one of the world's largest CDMOs. The company doesn't develop its own drugs, but rather contracts them for major companies, including gene therapy drugs and obesity hits (GLP-1). This chart shows the average price target from analysts, reflecting their view on the company's manufacturing capacity (the company is in the process of being acquired by Novo Nordisk).
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CTLT-Catalent-Inc.&v=1772624833738 "A chart showing analyst consensus forecasts for the expected stock price. CTLT (Catalent Inc.)")
The difference between the consensus estimate and the actual stock price CTLT (Catalent Inc.)
Catalent is a "factory" for Big Pharma. One of the world's largest contract manufacturing organizations (CDMOs), it helps other companies produce their drugs, from vaccines to gene therapies. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe in the growth of outsourcing in the pharmaceutical industry and its operational efficiency.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CTLT-Catalent-Inc.&v=1772624833761 "A chart showing the difference between the consensus forecast and the actual stock price. CTLT (Catalent Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Catalent is a "factory" for pharma giants. It's the largest contract manufacturer (CDMO), helping other companies produce their drugs (including gene therapy). This chart shows analysts' overall expectations for the pharma testing (CDMO) sector. It reflects whether experts believe outsourcing in the pharma industry will grow.
Analysts' consensus forecast for the overall market share price
Catalent is one of the world's largest contract manufacturers (CDMOs). The company doesn't develop its own drugs, but rather manufactures (fills and packages) medications for thousands of other pharmaceutical companies. This chart shows the overall market sentiment. For Catalent, operating behind the scenes in the protective pharmaceutical sector, the overall optimism is important, but their business is valued for its stability, as they manufacture already approved drugs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Catalent Inc.
Catalent is a factory for big pharma. It's one of the world's largest contract manufacturing organizations (CDMOs). Their specialty is complex manufacturing: sterile injections, gene therapy, and drug delivery. This chart is a barometer of their workload. It reflects their lumpy backlog of orders from biotechs and their (critical) role in filling blockbusters (like Ozempic).
AKIMA Market Segment Index - Pharma tests
Catalent is a factory for giants. They don't develop their own drugs, but rather act as a contract manufacturer (CDMO) for big pharma, producing vaccines, pills, and gene therapies. They outsource testing and manufacturing. This chart compares their composite index to the sector, showing how their service model outperforms the market.
The AKIM Index for the overall market
Catalent is one of the world's largest contract manufacturing companies (CDMOs) for pharmaceuticals and biologics. It's a partner for the pharma industry. It's being acquired by Novo Holdings. This chart, which reflects the market average, is a backdrop. It helps assess how contract manufacturing (CDMOs), a critical link in the drug supply chain, compares to overall macroeconomic trends.
